Distigmine bromide
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151540This classification denotes an acetylcholinesterase inhibitor with the molecular formula C22H32N4O4.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 750F36OP6J, chemically known as 3,3-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) dibromide but more generally known as distigmine bromide, which bears US NIH Compound Identifier 27522. European Medicines Agency schedules Distigmine bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06323MIG. The term DISTIGMINE BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). Most nations, for tariff and trade purposes, schedule distigmine bromide under HS 29333999 and SITC 51574. As of Q4 2014, DISTIGMINE BROMIDE remains US FDA's Preferred Term for this commodity. Distigmine bromide bears US NLM identifiers UMLS ID C0012757 and NCI Concept Code C87487. SMILES: C[N+]1CCCC(C1)OC(=O)N(C)CCCCCCN(C)C(=O)OC2CCC[N+](C2)C.[BR-].[BR-].
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.